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Abstract
Existing methods for paired antibody heavy- and light-chain repertoire sequencing rely on specialized equipment
and are limited by their commercial availability and high costs. Here, we report a novel simple and cost-effective
emulsion-based single-cell paired antibody repertoire sequencing method that employs only basic laboratory
equipment. We performed a proof-of-concept using mixed mouse hybridoma cells and we also showed that our
method can be used for discovery of novel antigen-specific monoclonal antibodies by sequencing human CD19+ B
cell IgM and IgG repertoires isolated from peripheral whole blood before and seven days after Td (Tetanus toxoid/
Diphtheria toxoid) booster immunization. We anticipate broad applicability of our method for providing insights
into adaptive immune responses associated with various diseases, vaccinations, and cancer immunotherapies.
Background
High-throughput sequencing of immunoglobulin reper-
toires from B cells has emerged as a powerful tool to
investigate repertoire changes for antibody discovery,
vaccine efficacy studies, and in other healthcare applica-
tions [1–3]. Initially, antibody repertoire analysis focused
on obtaining information from antibody heavy chains
(HC) only [4–7], missing the native light-chain (LC)
pairing information that is necessary for antibody
cloning and expression. Retaining paired HC-LC data
from bulk B cell populations at single-cell level remained
a major obstacle for a long time. To this end, several
single-cell paired sequencing technologies were reported
more recently, which were initially limited by low cell
numbers (< 400–105 cells) and sometimes required the
use of complex microfluidic systems [8–12]; however,
cellular throughput is improving through newer
developments, such as droplet-based systems and the
10× Genomics platform [13, 14]. More recently, two
emulsion-based methods reported paired HC-LC reper-
toire sequencing from 2–3 × 106 B cells at single-cell
level [15, 16]. Although substantial, the existing methods
are limited by their commercial availability, high costs,
and require an elaborate construction of flow-focusing
or microfluidic devices and dedicated personnel for
operation [17]. Here, we describe a high-throughput
method which enables sequencing of paired HC-LC
immunoglobulin (Ig) repertoires from millions of B cells
simply by using a cooled table-top centrifuge, a magnetic
stirrer, and a thermal cycler. This method makes paired
Ig sequencing widely applicable even for laboratories
without specialized equipment and personnel.
Methods
Cell lines
The HEK 293T cell line was obtained from the American
Type Culture Collection (ATCC CRL-3216). Mouse
hybridoma cell lines KT13 and KT22 were obtained
from the Developmental Studies Hybridoma Bank
(DSHB). Both cell lines were deposited to the DSHB by
Kazumasa Takeda and Asako Sugimoto (DSHB hybridoma
products KT13 and KT22). Mouse hybridoma cell line
5E4/1F1 was kindly provided by Miha Kosmač and Vladka
Čurin Šerbec (University of Ljubljana). HEK 293T and
hybridoma cells were grown in DMEM (Gibco)
supplemented with 13% FBS (Gibco), 1× Penicillin/
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Streptomycin (Thermo Fisher), and 1× GlutaMAX
(Gibco). Antibody HC and LC sequences from individual
hybridomas were determined by reverse transcription
polymerase chain reaction (RT-PCR) and capillary sequen-
cing (Eurofins Genomics).
Cycloheximide treatment and microsome preparation
All pipetting steps were performed on ice and centrifuga-
tions were carried out at 4 °C using an Eppendorf 5810R
centrifuge with fixed angle rotor F-45-30-11. Protein
LoBind 1.5 mL centrifuge tubes (Eppendorf) were used to
minimize cell adhesion to the tube walls. HEK 293T cells
(1 million), mouse hybridoma cells (1 million of 5E4,
KT13, and KT22 cells mixed in ratio 1:1:1), ARH-77
leukemia cells (ATCC CRL-1621, 1 million), or freshly
isolated human CD19+ B cells from pre- and post Td-
booster immunization samples (1.5 million each) were
resuspended in 1 mL PBS with 50 μg/mL cycloheximide
and incubated for 10 min to stall ribosomes with associ-
ated messenger RNAs (mRNA) at the rough endoplasmic
reticulum. The cells were pelleted with 300 g for 10 min
at 4 °C and resuspended by pipetting 15× up and down in
120 μL high-density lysis buffer (25 mM HEPES-KOH
pH 7.2, 110 mM potassium acetate, 5 mM magnesium
acetate, 1 mM EGTA, 25% [w/w] sucrose [0.81 M], 5% [v/v]
glycerol, 1 mM 1,4-dithiothreitol, 1× cOmplete EDTA-free
protease inhibitor cocktail [Roche], 0.1 mg/mL cyclohexi-
mide, 0.015% digitonin, and 400 U/mL RiboLock RNase
inhibitor [Thermo Fisher Scientific]). Cell and organelle lysis
was completed by incubation for 10 min on ice. Each
homogenate was split into two 55 μL aliquots and trans-
ferred into two fresh Protein LoBind tubes. The tubes were
centrifuged at 600 g for 3 min at 4 °C to pellet nuclei and
cell debris. A total of 40 μL supernatant from each
tube, containing membrane fractions and cytosol,
were transferred into fresh Protein LoBind tubes and
the sucrose concentration was diluted to 0.37–0.40 M
(12–13% w/w) by the addition of 40 μL nuclease-free
water. Microsomes were then sedimented by centrifu-
gation with 20,800 g for 120 min at 4 °C. The
cytosol-containing supernatants were discarded and
membrane pellets were resuspended by pipetting
10× up and down in 85 μL wash buffer (25 mM
HEPES-KOH pH 7.2, 110 mM potassium acetate, 2.
5 mM magnesium acetate, 1 mM EGTA, 1 mM 1,4-
dithiothreitol, 1× cOmplete EDTA-free protease
inhibitor cocktail, 0.1 mg/mL cycloheximide, 0.004%
digitonin, and 400 U/ml RiboLock RNase inhibitor).
The microsomes were sedimented again by centrifu-
gation with 20,800 g for 60 min at 4 °C. Superna-
tants were discarded and the microsome pellets
were resuspended in 20 μL of wash buffer and kept
on ice until further use.
Transmission electron microscopy
Sample aliquots of 3.5 μL of resuspended HEK 293T
microsomes were applied to freshly glow-discharged
Quantifoil grids (Quantifoil, Germany) covered with an
additional 2 nm carbon support film and flash-frozen in
liquid ethane using a Vitrobot plunger (FEI). Samples
were imaged on a Tecnai Spirit transmission electron
microscope (FEI) operated at 120 kV equipped with a
2 × 2 k Eagle CCD camera (FEI). Micrographs were re-
corded under cryo low-dose conditions at 42,000× nom-
inal magnification (pixel size at object scale: 5.2 Å/px)
applying a defocus of − 2 to − 4 μm. Data collection was
performed either manually or fully automatically using
Leginon [18].
Emulsion RT-PCR assembly using mouse hybridoma
microsomes
We diluted 16 μL of resuspended microsomes from
mixed hybridomas 5E4, KT13, and KT22 in 184 μL RT-
PCR master mix containing 1× Verso 1-Step RT-PCR
master mix (Thermo Scientific), 1× Verso enzyme mix
(Thermo Scientific), 0.5 μg/μL BSA, 100 μg/mL cyclo-
heximide, and primers for reverse transcription and HC
and LC assembly (0.8 μM each of primers TitA_MID1_
IgM_rev and TitB_MID12_IgK_rev; 0.16 μM each of
primers OE_MHV_fwd and OE_MKV_fwd). Primer se-
quences are shown in Additional file 1: Figure S1a. The
resulting 200 μL of aqueous solution were used to form
a water-in-oil emulsion by dropwise addition (13
aliquots of 15 μL in 30-s intervals) to 800 μL oil phase
according to Ge et al. [19] (Mineral oil, Sigma M5904,
with 4.5% [v/v] Span 80, Sigma S6760, 0.4% [v/v] Tween
80, Sigma P8074, and 0.05% [v/v] Triton X-100, Sigma
T8787) during continuous stirring on a magnetic stirrer.
Six aliquots of 100 μL each of the resulting emulsion
were transferred into PCR tubes and subjected to ther-
mocycling with the following conditions: reverse tran-
scription at 50 °C for 15 min, RTase inactivation at 95 °C
for 2 min, then four cycles of denaturation at 95 °C for
20 s, annealing rampdown from 60 °C to 50 °C for 50 s
and extension at 72 °C for 1 min, then 16 cycles of
denaturation at 95 °C for 20 s, annealing at 60 °C for
30 s and extension at 72 °C for 1 min, followed by a final
extension step at 72 °C for 5 min. In parallel, an open
RT-PCR control was performed by diluting 4 μL of
resuspended microsomes in 46 μL RT-PCR master mix
and thermocycling the reaction in parallel with the
emulsion RT-PCR. PCR assembly products were
extracted from the emulsion using isobutanol (2-Methyl-
1-propanol, Sigma) and the Zymo DNA Clean &
Concentrator-5 kit (Zymo Research) as previously pub-
lished [20]. The resulting DNA and the PCR product
from the open PCR control were loaded on a 1.2% TBE-
agarose gel and separated with 90 V for 60 min.
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Assembly products of 800–950 bp size were size-
selected from the agarose gel and the products were
recovered using a Zymoclean Gel DNA Recovery kit.
Assembly products were eluted in 6 mM Tris-Cl pH 8
and stored at − 20 °C until further analysis.
Nested PCR amplification of mouse hybridoma assembly
products
After the emulsion assembly reaction, the assembly
products were further amplified with adapter primers
TitA_fwd, 5’ CGT ATC GCC TCC CTC GCG CCA
TCA G 3′, and TitB_rev, 5’ CTA TGC GCC TTG CCA
GCC CGC TCA G 3′, using the Phusion high-fidelity
DNA polymerase kit (Finnzymes) with the following
thermocycling conditions: Initial denaturation at 98 °C
for 30 s, then 15 cycles of denaturation at 98 °C for 7 s
and annealing/extension at 72 °C for 30 s, followed by a
final extension step at 72 °C for 5 min. PCR products
were purified with the Zymo DNA Clean &
Concentrator-5 kit. The pairing of HC and LC in the
assembly products were then analyzed by PCR using
nested primers specific for the three different HC and
three different LC (Additional file 1: Figure S1e) using
the Phusion high-fidelity DNA polymerase kit with the
following thermocycling conditions: initial denaturation
at 98 °C for 30 s, then 24 cycles of denaturation at 98 °C
for 7 s and annealing/extension at 72 °C for 30 s,
followed by a final extension step at 72 °C for 5 min.
Nested PCR products were loaded on a 1.2% TBE-
agarose gel and separated with 90 V for 40 min.
Real-time nested PCR for quantification of cross-
contamination was carried out in triplicates with the
same nested primers using SYBRGreen master mix
(Applied Biosystems) on a StepOne qPCR cycler
(Applied Biosystems) with the following thermocycling
conditions: initial denaturation at 95 °C for 10 min,
followed by 40 cycles of denaturation at 95 °C for
15 s, annealing at 56 °C for 30 s and extension at
72 °C for 45 s. The initial abundances of the
amplified assembly products were calculated using the
2^(-deltaCt) method and plotted as bar charts with
error bars showing standard deviation from the mean.
Immunization and CD19+ B cell isolation from peripheral
whole blood samples
The human peripheral whole blood samples used in
this study were obtained from in.vent Diagnostica
GmbH as by-products from routine diagnostic
procedures. in.vent Diagnostica GmbH has written
informed consent from the donor to use the by-
products for research and has an ethical approval
from the Freiburg Ethics Commission International
(FEKI code 011/1763) for the distribution of samples.
A healthy proband underwent booster immunization
with Tetanus Toxoid (TT)/Diptheria Toxoid (DT)
(Td-pur®; 20 International units [IU] TT and 2 IU
DT; Novartis, Basel, Switzerland). K2-EDTA peripheral
whole blood derived from pre-immunization (day 0) and
seven days post-Td booster immunization were used to
isolate CD19+ B cells using the CD19 pluriBead Cell
Separation Kit (pluriSelect GmbH, Leipzig, Germany)
following the manufacturer’s protocol. Isolated CD19+ B
cell pellets were washed in 1 mL cold PBS and centrifuged
at 300 g for 10 min at 4 °C. Cell pellets corresponding to
1.5 million B cells from both pre- and post-immunization
samples were kept on ice until cycloheximide treatment
and microsome preparation.
Emulsion RT-PCR assembly using human B cell
microsomes
We added 2 μL of diluted microsomes prepared from
frozen ARH-77 cells (as internal pairing control) to
26 μL of resuspended microsomes from B cells both
pre- and post-Td immunization, so that the final fraction
of ARH-77 microsomes is 0.5% (v/v). We diluted 16 μL
of this microsomes suspension in 184 μL RT-PCR
master mix containing 1× dART 1-step RT-PCR master
buffer mix (Roboklon), 2× dART master enzyme mix
(Roboklon), 0.5 μg/μL BSA, 100 μg/mL cycloheximide
and primers for reverse transcription (IgM, IgG, and
IgK) and heavy (VH) and light chain (VK) assembly.
Primer sequences and concentrations in the RT-PCR
master mix are listed in Additional file 1: Table S2. The
resulting 200 μL of aqueous solution were used to form
a water-in-oil emulsion by dropwise addition (13
aliquots of 15 μL in 30 s intervals) to 800 μL oil phase
composed of 73% emulsion component 1, 7% emulsion
component 2, and 20% emulsion component 3 of the
Micellula DNA emulsion and purification kit (Roboklon)
during continuous stirring on a magnetic stirrer. Six ali-
quots of 100 μL each of the resulting emulsion were
transferred into PCR tubes and subjected to thermocy-
cling with the following conditions: Reverse transcrip-
tion at 55 °C for 30 min, initial denaturation at 95 °C for
3 min, then three cycles of denaturation at 95 °C for
20 s, annealing at 56 °C for 30 s and extension at 72 °C
for 2 min, then 20 cycles of denaturation at 95 °C for
20 s, annealing at 56 °C for 30 s and extension at 72 °C
for 4 min, followed by a final extension step at 72 °C for
5 min. PCR assembly products were extracted from the
emulsion using isobutanol (2-Methyl-1-propanol, Sigma)
and the Zymo DNA Clean & Concentrator-5 kit (Zymo
Research) as previously published [20]. The resulting
DNAs were loaded on a 1% TBE-agarose gel and
separated with 100 V for 45 min. Assembly products of
700–800 bp were size-selected from the agarose gel,
recovered using a Zymoclean Gel DNA Recovery kit,
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eluted in 6 mM Tris-Cl pH 8, and stored at − 20 °C until
further analysis.
Nested PCR amplification of human B cell assembly
products
For specific further amplification of the HC-LC assembly
products, a nested PCR amplification was performed
with nested primers specific for IgM, IgG, and IGK con-
stant regions (Additional file 1: Table S2). The PCR reac-
tion contained nested primers at 0.4 μM concentrations,
200 μM dNTP mix, 1× Q5 reaction buffer and 0.02 U/μL
Q5 high-fidelity DNA Polymerase (New England Biolabs)
in a reaction volume of 50 μL with 3 μL of assembled
DNA. Nested PCR amplification was performed with the
following thermocycling conditions: initial denaturation at
98 °C for 3 min, then 34 cycles of denaturation at 98 °C
for 30 s and annealing/extension at 71 °C for 1 min,
followed by a final extension step at 72 °C for 5 min.
Samples were collected after three different PCR cycle
numbers (28, 31, and 34 cycles). Amplified PCR products
were loaded on 1% TBE-agarose gels and separated with
100 V for 60 min. The desired products of ~ 710 bp were
extracted as described above, sequencing libraries were
prepared following the Illumina TruSeq DNA sample
preparation guide and 2 × 250 base paired-end reads were
sequenced using the Illumina MiSeq platform.
Bioinformatic analysis of paired antibody heavy and light
chain repertoires
Demultiplexing of 2 × 250 base paired-end reads from
the MiSeq sequencing platform was performed based on
adapter indices and sequencing data were obtained in
fastq format. Only reads with minimum Phred quality
scores of 10 over 50% of all nucleotides were retained
and scanned for IgM, IgG, and IgK constant region
sequences. Read pairs lacking constant region sequences
or showing HC-HC or LC-LC structure were filtered out
and the remaining reads were converted into fastq
format and used as input for analysis with MiXCR (v1.2)
[21] for alignment of reads to reference V(D)J and C
gene sequences from the IMGT database [22],
extraction, and clustering of CDR-H3 nucleotide
(Additional file 1: Table S1). HC-CDR3 sequences con-
taining frameshifts or stop codons and with less than
two reads were filtered out. We created a HC-LC pairing
statistics file to demonstrate paired VH-VK gene usage
in the total paired HC-LC gene repertoires. Heat maps
were generated using R and graphically displayed using
ggplot2. Next, inter-individual TT-specific HC-CDR3
sequences were identified by comparing HC-CDR3
amino acid sequences obtained from the post-Td booster
immunization sample to previously reported TT-specific
HC-CDR3 sequences [23–26].
PCR amplification of full-length HC and LC sequences
We designed a two-step PCR-based amplification
method (Additional file 1: Figure S5) to incorporate
restriction digestion sites to potentially TT-specific HC
and LC with complete V(D)J gene sequence. This
enabled efficient cloning of HC and LC sequences into
respective expression vectors as well as production of
recombinant antibodies for in vitro binding studies.
Briefly, we selected 14 paired HC-LC CDR3 clonotypes
obtained from IgG sequencing post-Td booster
immunization based on their frequency, pairing accur-
acy, and fold difference between top1 LC-CDR3 and
top2 LC-CDR3 paired to the given HC-CDR3 sequence.
We extracted total RNA from frozen B cells isolated
from post-Td booster immunization using TRIzol
reagent (Ambion) purification according to the manufac-
turer’s instructions. In the first step, RT-PCR amplifica-
tion for each selected HC- and LC-CDR3 clonotype was
performed separately using the dART 1-step RT-PCR kit
(Roboklon). The RT-PCR master mix (25 μL) contained
HC and LC V gene-specific forward primers with BssHII
restriction site overhangs together with individual
CDR3-specific reverse primers with 18 nucleotides of
FR4 region at 0.4 μM concentrations (Additional file 1:
Table S3 and Figure S5), 1× dART 1-step RT-PCR mas-
ter buffer mix, 1× dART master enzyme mix, and 4.5 ng
total RNA. Thermocycling conditions were as follows:
reverse transcription at 55 °C for 30 min, initial denatur-
ation at 95 °C for 3 min, then 23 cycles of denaturation
at 95 °C for 20 s, annealing at 56 °C for 30 s and exten-
sion at 72 °C for 90 s, followed by a final extension step
at 72 °C for 5 min. RT-PCR products were purified using
the Agencourt AMPure XP – PCR purification kit
(Beckman Coulter) following the manufacturer’s instruc-
tions and eluted in 6 mM Tris-Cl pH 8.0. In the second
step, purified RT-PCR products were used as template
for PCR amplification using Q5 high-fidelity DNA poly-
merase (New England Biolabs). The nested PCR master
mix (50 μL) contained forward primers encoding a
BssHII restriction site and three nucleotides of HC or
LC germline gene sequence together with reverse
primers containing the complete FR4 region and NheI/
HindIII restriction overhangs at 0.4-μM concentrations
(Additional file 1: Table S3 and Figure S5), 4 μL of puri-
fied DNA, 200 μM dNTP mix, 1× Q5 reaction buffer,
and 0.02 U/μL Q5 high-fidelity DNA Polymerase (New
England Biolabs). Thermocycling conditions were as
follows: initial denaturation at 98 °C for 3 min, then
16 cycles of denaturation at 98 °C for 30 s, annealing at
69 °C for 30 s and extension at 72 °C for 1 min, followed
by a final extension step at 72 °C for 5 min. PCR prod-
ucts were separated on a TBE-agarose gel, full-length
HC and LC amplicons with restriction digestion sites
were extracted from the gel using the Zymoclean Gel
Devulapally et al. Genome Medicine  (2018) 10:34 Page 4 of 12
DNA Recovery Kit (Zymo Research) and products were
stored at − 20 °C until further use.
Cloning and expression of recombinant monoclonal
antibodies
Restriction digestion of full length HC and LC inserts
and expression vectors (pCMV-CD30-4IE3_HC and
pCMV-CD30-4IE3_LC) was performed with the restric-
tion enzymes BssHII, NheI and HindIII (New England
Biolabs). The resulting products were loaded on 2%
TBE-agarose gels and bands of ~ 5.9 kb for the HC
vector backbone, 5.3 kb for the LC vector backbone,
~ 370 bp for HC inserts, and ~ 340 bp for LC inserts
were size-selected on agarose gels and purified as
described above. Ligations of the corresponding
inserts and vectors for the amplified HC and LC
clonotypes were performed using instant sticky-end
DNA ligase (New England Biolabs) and transformed
into one-shot chemically competent E. coli TOP10
cells (IBA) following the manufacturer’s instructions.
Plasmid DNAs were isolated from transformed col-
onies (8–16 colonies) using the QIAprep spin mini-
prep kit (Qiagen); similarities to the consensus
sequences were confirmed using capillary Sanger se-
quencing. HC and LC plasmid DNA sequences that
matched closest to the consensus sequences were co-
transfected into human embryonic kidney cell line
HEK 293 T (ATCC, CRL-11268) cells. HEK 293 T
cells were cultured using rich glucose (4.5 g/L D-
glucose) Dulbecco’s Modified Eagle’s Medium (Gibco
BRL) supplemented with heat-inactivated ultra-low
IgG fetal bovine serum (Thermo Fisher Scientific),
100 U/mL penicillin, and 100 μg/mL streptomycin.
Purified plasmid DNAs for paired HC and LC clono-
types were co-transfected into 85–95% confluent HEK
293 T cells using PEI (polyethyleneamine, Polysciences).
Culture supernatants were collected four days after trans-
fection and TT antigen-specific clonotypes were identified
by indirect ELISA.
Enzyme-linked immunosorbent assays (ELISA)
We performed indirect ELISA assays to identify mAbs
derived from the immunized proband binding to TT
antigen using the transfected cell culture supernatants.
Nunc-Immuno MicroWell 96-well solid plates (Thermo
Fisher Scientific) were coated with 100 μL of 10 μg/mL
TT antigen (Statens Serum Institute, Copenhagen,
Denmark) in 50 mM carbonate buffer pH 9.6, incubated
overnight at 4 °C, washed three times with PBS, and
blocked with 2% non-fat dried milk (Bio-Rad) in PBS for
150 min at room temperature. After blocking, 120 μL of
1:2 serially diluted transfected supernatants in PTM
(PBS, 0.1% Tween-20, 2% non-fat dried milk) were
added to the wells, 350 ng of mouse anti-TT mAb
(GeneTex) was applied to one well as a positive control,
and plates were incubated for 1 h at room temperature.
Plates were washed three times with PBS-T (0.1%
Tween-20) and 50 μL of a 1:2000 dilution of goat anti-
human kappa LC-HRP secondary antibody (Thermo
Fisher Scientific) were added to the wells, 50 μL of a 1:
2000 dilution of goat anti-mouse IgG HC-HRP second-
ary antibody (Sigma #A0168) were added to the positive
control well, plates were incubated for 2 min at room
temperature and washed three times with PBS-T. For
color development, we added 50 μL of one-step Ultra
TMB-ELISA substrate (Thermo Fisher Scientific) per
well, incubated the plates for 5 min at room
temperature, and stopped the Ag:Ab binding reaction by
addition of 50 μL 2 M H2SO4. The absorbance was
measured at 450 nm using the GloMax Multi Detection
System (Promega). ELISA assays for all clonotypes were
performed in triplicates, the values were normalized to
remove background signals, and errors were represented
as standard deviations from the mean.
Analysis of chimeric amplicon formation during nested
PCR
Four defined HC-LC amplicons were generated by
amplifying the HC and LC from the respective pCMV
plasmids (see above) and using a PCR assembly reaction
to generate the four distinct HC-LC assemblies. HC and
LC plasmid DNAs were used as templates for PCR amp-
lification of the Top1, Top2, Top3, and Top4 clonal
chain pairs using primers specific for the respective VH
and VK gene families and IgG and IgK constant regions
(Additional file 1: Table S2 and Figure S6a). Purified
plasmid DNA (10 ng) was added to each 25 μL PCR
reaction containing 0.4 μM of each primer, 200 μM
dNTP mix, 1× Q5 reaction buffer, and 0.2 U/μL Q5
high-fidelity DNA Polymerase. Thermal cycling was per-
formed with initial denaturation at 98 °C for 3 min,
followed by 25 cycles of denaturation at 98 °C for 30 s,
annealing/extension at 71 °C for 1 min (for HC plasmid
DNA) or annealing at 64 °C for 1 min and extension at
72 °C for 1 min (for LC plasmid DNA), followed by a
final extension step at 72 °C for 5 min. PCR products
were loaded onto separate 1% TBE-agarose gels and
separated with 100 V for 60 min. The desired DNA
products of ~ 400 bp (for HC) and ~ 350 bp (for LC)
were size-selected and extracted from the gel as described
above. The purified HC and LC PCR products were used
as templates for HC and LC assembly by overlap exten-
sion PCR (Additional file 1: Figure S6b). Briefly, 5 ng of
each HC and corresponding paired LC DNA were added
into each 50 μL PCR reaction containing 1× dART 1-step
RT-PCR master buffer (Roboklon), 2× dART master
enzyme (Roboklon), and 0.4 μM of each IgG and IgK
constant region primer (Additional file 1: Table S2).
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Thermal cycling was performed with RT inactivation at
95 °C for 3 min, followed by three cycles of denaturation
at 95 °C for 20 s, annealing at 56 °C for 30 s and extension
at 72 °C for 2 min, followed by 25 cycles of denaturation
at 95 °C for 20 s, annealing at 56 °C for 30 s and extension
at 72 °C for 4 min, followed by a final extension step at
72 °C for 5 min. The assembly products were loaded onto
1% TBE-agarose gels and separated with 100 V for
45 min. The assembly products of ~ 750 bp were size-
selected and extracted from the agarose gel as described
above. The individually assembled HC-LC clonal pairs
were pooled together and used as template for nested
PCR amplification with primers specific for IgG and IgK
constant regions (Additional file 1: Table S2, Figure S6c).
The nested PCR reaction and thermal cycling conditions
were the same as described in the “Nested PCR amplifica-
tion of human B cell assembly products” section except
that the PCR amplification was performed for 25 cycles.
PCR products were loaded onto 1% TBE-agarose gels,
separated with 100 V for 60 min and desired products of
~ 720 bp were extracted as described above. Sequencing
libraries from the individual assemblies and from the
mixed assemblies after nested PCR were prepared follow-
ing the Illumina TruSeq DNA sample preparation guide
and 2 × 250 base paired-end reads were generated using
the Illumina MiSeq platform.
Results
Microsome-associated mRNAs can be used to retain
native antibody HC-LC pairs with high pairing accuracy
Our approach is based on the concept that each B cell
contains rough endoplasmic reticulum (rER) with bound
ribosomes for co-transcriptional translocation of
secretory proteins. These bound ribosomes are thus
associated with both Ig HC and LC mRNAs, located at
translocon complexes [27], which are translated into
membrane-bound or secretory antibodies. We reasoned
that rER microsomes obtained after cell lysis should
retain the correctly paired HC and LC mRNAs of each
individual B cell and thus represent the smallest sub-
cellular entity comprising both types of mRNAs. It is
likely that several microsomes are generated from each
cell which leads to a higher clonal redundancy for a
more efficient library synthesis when compared to using
whole cells as templates. Therefore, these microsomes
can subsequently be used for clonal RT-PCR assembly of
the two chains from the original single cells, providing
that the derived microsomes are separated into individ-
ual reaction vessels, a step that we have carried out by
using water-in-oil emulsions. The entire workflow is
summarized in Fig. 1.
We developed our method using HEK 293T cells
based on a protocol for preparation of microsomes from
plant material [28]. To preserve the mRNAs at rER
translocon complexes, we first treated the cells with the
protein synthesis inhibitor cycloheximide [29] to retain
stalled ribosomes with associated mRNAs in the result-
ing microsomes. The cycloheximide-treated cells were
incubated in a sucrose buffer containing 5% digitonin,
leading to the lysis of cells and organelles during which
rER sheets collapse and form multilayered structures
preserving the mRNA transcripts while keeping the cell
nuclei intact. The sucrose provides higher density inside
the lysed microsomes. Then, cell debris, nuclei, non-
secretory mRNAs, and mitochondria were removed by
low-speed centrifugation (600 g). This purification step
has the advantage to greatly reduce PCR artefacts due to
off-target amplification by mispriming on genomic DNA
and other mRNAs. The microsome-containing super-
natant was diluted with water so that microsomes could
subsequently be pelleted based on their higher buoyant
density using high-speed centrifugation (20,800 g) in a
cooled table-top centrifuge. After removal of the super-
natant (cytosol), the microsomes were resuspended in
wash buffer and sedimented again (20,800 g) to further
enrich microsomes for downstream applications (Fig. 1b).
For verification of our microsome preparation method,
enriched rER-microsomes from HEK 293T cells were visu-
alized using transmission electron microscopy (Fig. 1c).
We observed that the majority of microsomes were com-
posed of multi-lamellar vesicles of approximately spherical
shape, while some others were of uni-lamellar structure.
This result suggested that our method can be used to
obtain stable rER microsomes, thus avoiding the use of
tedious ultracentrifugation steps [28].
Next, we tested if the enriched rER microsomes could
be used for clonal assembly and amplification of paired
immunoglobulin HC-LC from single cells. For this, we
mixed cells from three mouse hybridoma cell lines with
known Ig HC and LC sequences (cell lines 5E4, KT13,
and KT22) and prepared microsomes from the cell mix
according to our protocol (Fig. 1a and b, Additional file 1:
Figure S1). We then passed the microsomes into water-
in-oil emulsion droplets containing RT-PCR assembly
master mix with overlap extension primers (Fig. 1d),
wherein, based on Poisson statistics, the vast majority of
individual microsomes were encapsulated in separate
emulsion droplets (Fig. 1e). If clonal pairing and amplifi-
cation occur, the amplified sequences should be strongly
enriched for the three correct chain pairs among the
nine possible pairings of three different HCs and LCs
(Additional file 1: Figure S1). Within the emulsion drop-
lets, the HC and LC mRNAs from individual micro-
somes were reverse transcribed using isotype-specific
primers (IgM and IgK), assembled by overlap extension
PCR and amplified. After size selection of the assembled
DNA on an agarose gel, subsequent nested PCR with
hybridoma-specific primers showed that the three
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correct chain pairs were strongly enriched (> 95%) versus
the nine possible permutations (Fig. 1f, upper panel, and
Additional file 1: Figure S1). In contrast, we observed no
enrichment of the correctly paired chains in control
experiments performed in parallel where the assembly
was carried out in conventional open PCR without
emulsification, leading to an evenly balanced random
chain assembly (Fig. 1f, lower panel). We quantified the
amount of cross-contamination in the assembled DNA
using real-time quantitative PCR (Additional file 1:
Figure S1f) and found that cross-contamination among
the distinct hybridomas was present at 0.2% frequency,
while 99.8% of the chains demonstrated correct pairing.
These results show that our method is suitable for clonal
amplification of paired Ig HC and LC from single cells
with high pairing accuracy.
A scalable high-throughput sequencing platform to retain
native antibody HC-LC pairs from single B cells
We then applied our method to study immunization-
induced changes in CD19+ B cell repertoires from
pre- (day 0) and post- (day 7) Td booster
immunization (Fig. 2). We used 1.5 million CD19+ B
cells freshly isolated from peripheral whole blood
samples of a healthy donor both pre- and post-Td
booster immunization and prepared microsomes
enriched with rER. As a control for native HC-LC
pairing, we prepared microsomes from frozen ARH-
77 cells expressing known IgG HC and IgK LC
sequences and spiked 0.5% (v/v) of ARH-77 micro-
somes into B cell-derived microsomes (Additional file 1:
Table S1). The microsomes were passed into water-
in-oil emulsion droplets for amplification in two sep-
arate reactions with primers specific for IgM and IgG
isotypes, respectively. After emulsification, overlap-
extension RT-PCR, and nested PCR (Additional file 1:
Figure S2), we prepared Illumina TruSeq libraries
from the nested PCR amplicons and performed
sequencing on the Illumina MiSeq with paired reads
of 2 × 250 bases (Additional file 2: Figure S3). The
raw sequencing reads were quality filtered and anno-
tated to define the individual HC (IgM or IgG) and
a b c
d e f
Fig. 1 Overview of paired antibody HC-LC amplification using microsomes in water-in-oil emulsion droplets. a Antibody-expressing cell populations
were used for microsome preparation. b Cells were lysed using a sucrose buffer with 5% digitonin and microsomes with rER-associated mRNAs were
enriched using differential centrifugation. c Transmission electron microscopy showed enriched rER microsomes with multilamellar and unilamellar
structures. The image was acquired from HEK 293T microsomes used for establishment of the method. Scale bar represents 100 nm. d HC and LC
mRNAs were assembled by overlap extension RT-PCR to generate natively paired HC-LC amplicons using constant region primers for reverse transcription
and variable region primers for overlap extension assembly. The location and orientation of the paired-end MiSeq reads on the amplicons are indicated by
red arrows. e The assembly reaction was carried out within individual emulsion droplets with microsomes from single cells for clonal assembly of rER-
associated mRNAs. f Nested PCR amplification with hybridoma-specific nested primers on the assembled DNA demonstrated strong enrichment of native
HC-LC pairs when using emulsion PCR during the assembly reaction (upper panel), while a control showed random pairing of heavy and light chains when
using conventional open PCR during the assembly reaction
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LC (IgK) isotypes. The annotated reads were aligned
to the human Ig germline genes (IMGT annotation
[22]) and clustered using MiXCR [21] to determine
the number of unique paired CDR3 clones (requiring
≥ 2 reads per pair) including correction of PCR errors.
From the pre-immunization sample, we identified a
total of 2200 and 4841 HC-LC pairs for IgM and
IgG, respectively (Additional file 2: Data files S1 and
S2). The post-Td immunization sample resulted in
4031 and 2872 HC-LC pairs for IgM and IgG, re-
spectively (Additional file 2: Data files S3 and S4).
Among these, we identified 212 (IgM) and 125 (IgG)
HC-CDR3 clonotypes that were present in both the
pre- and post-Td immunization samples. Of these, 50.
0% (IgM) and 60.0% (IgG) of the HC-CDR3s found in
pre- and post-Td booster immunization data shared the
same LC-CDR3 sequences, demonstrating the application
of this technology to identify and track pre-existing B
cells, possibly from the antigen-specific memory B cell
compartment [30] (Additional file 2: Data files S5 and S6).
The ARH-77 spike-in HC-LC pairing demonstrated pref-
erential pairing of the known HC with the correct corre-
sponding LC (Additional file 1: Figure S4). Of the IgM
and IgG isotypes pre- and post-Td immunization, the top
ten pairs constituted 57% and 49% (for IgM isotype) and
61% and 76% (for IgG isotype) of the total aligned reads,
respectively, indicating a clonotype distribution that is
skewed towards the most frequent HC-LC pairs.
We then generated heat maps showing the HC-LC
pairing frequencies of all aligned reads and observed
strong changes in VH gene family usage and expansion
of certain B cell clones in response to antigen stimula-
tion [2, 23, 30, 31]. Specifically, we found that certain
VH-VK pairings (e.g. VH3-VK1, VH4-VK1, and VH4-
VK3) were highly frequent (up to 78% of total reads) in
the pre-immunization samples for both the IgM and IgG
isotypes (Fig. 2b and d). Post Td booster immunization,
other pairings such as VH1-VK1, VH1-VK2, VH3-VK1,
and VH4-VK1 were predominantly observed in both
IgM (Fig. 2c) and IgG (Fig. 2e) isotypes. We also
identified rare HC-LC pairs (e.g. VH7-VK5 and VH7-
VK6) that are generally observed at lower frequencies
(Fig. 2b–e), as reported in prior studies [10, 32]. This
result illustrates the sensitivity of our technique to
identify rare clonal pairs.
We quantified the presence and frequency of promis-
cuous LC sequences (LC paired to more than one spe-
cific HC) among all identified HC-LC pairs in all four
samples (Additional file 3: S1-S4). We observed that
three samples (IgG pre- and post- immunization, and
IgM pre-immunization) contained 15–17% promiscuous
LC, while one sample (IgM post-immunization) showed
a higher frequency of 38.7% promiscuous LC. These
observations are in line with previous studies reporting
LC promiscuity due to lower theoretical diversity of LC
junctions [15, 33]. We further compared the IgG HC-
a b c
ed
Fig. 2 Gene usage of different immunoglobulin VH and VK gene families observed in paired HC-LC gene repertoires before and after Td booster
immunization. a CD19+ B cells were isolated from freshly derived peripheral whole blood from a healthy proband before (day 0) and after (day 7)
Td booster immunization. Amplification of paired antibody HC-LC repertoires was performed as described in Fig. 1 and paired libraries were
sequenced on the Illumina MiSeq platform. Each panel represents sequencing data obtained from one independent emulsion RT-PCR assembly
reaction. b IgM HC-LC pairing frequencies from pre-immunization CD19+ B cell sample (total aligned reads: 5,238,212; final clonotype count:
2200). c IgM HC-LC pairing frequencies from seven days post-Td booster immunization (total aligned reads: 4,647,787; final clonotype count:
4031). d IgG HC-LC pairing frequencies from pre-immunization CD19+ B cell sample spiked with 0.5% ARH-77 microsomes (total aligned reads:
4,411,684; final clonotype count: 4841). e IgG HC-LC pairing frequencies from seven days post-Td booster immunization CD19+ B cell sample
spiked with 0.5% ARH-77 microsomes (total aligned reads: 4,332,934; final clonotype count: 2872). Colors indicate percentage of reads for indicated
VH-VK pairings among all reads in the analyzed B cell repertoire
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CDR3 amino acid sequences obtained from post-Td
booster immunization with TT-specific HC-CDR3
sequences from previous studies [24–26, 30]. We found
two previously reported TT antigen-specific HC-CDR3
sequences in our dataset (CARQADNWFDPW and
CATGRTLDYW) [24, 30], suggesting the suitability of
our method to track known sequences related to
diseases and autoreactive antibodies [2].
Application of paired antibody HC-LC repertoire
sequencing for antigen-specific mAb discovery
Finally, we demonstrated that our paired sequencing
technique is suitable for the discovery of novel antigen-
specific human monoclonal antibodies (mAbs) by per-
forming antibody cloning, expression and antigen bind-
ing studies using ELISA. We selected 14 highly induced
HC-LC pairs from the IgG B cell repertoire post-Td
booster immunization, including the HC-LC pair for one
previously reported TT-specific HC-CDR3 sequence
(CARQADNWFDPW) (Fig. 3a). We used a two-step
PCR strategy for incorporating restriction digestion sites
to the selected HC-LC pairs (Additional file 1: Figure
S5) for cloning into IgG HC and LC expression vectors.
For recombinant mAb production, the HC and corre-
sponding LC plasmids were co-transfected into HEK
293T cells (Additional file 1: Figure S5) and IgG-
containing cell culture supernatants were harvested on
day 4 after transfection. We performed indirect ELISA
experiments with the transfected cell supernatants using
plates coated with TT antigen and identified four novel
TT-specific mAbs, named Top1, Top2, Top3, and Top4
here (Fig. 3b). Interestingly, the Top2, Top3, and Top4
HC-LC pairings were also present in the sequenced
pre-immunization repertoire, albeit at much lower
frequencies (< 0.1% of total reads), suggesting the clonal
expansion of pre-existing clonotypes after antigen expos-
ure [30]. However, the previously reported TT-specific
HC-CDR3 clonotype CARQADNWFDPW did not bind
to TT antigen using our experimental setup (Fig. 3b),
probably because it is a so-called public rearrangement
with limited introduction of N/P nucleotides that is asso-
ciated to IGHV4–39 and IGKV5–2 in our study, while
similar TT-specific binders with this type of CDR3 are as-
sociated to IGHV4–30-2 and IGKV3–15. Also, the paired
LC-CDR3 was different in our study (CLQHDDFPLTF)
compared to the LC-CDR3 previously identified from a
TT-binding memory B cell (CQQYYNWPPYTF) [26].
Our results show that almost one-third (29%) of the se-
lected antibodies identified by our method did bind to TT
antigen, thus demonstrating the applicability of this
method for rapid discovery of mAbs using native Ig chain
pairing information from B cells.
Immune repertoire sequencing methods can be
affected by the formation of chimeric amplicons during
PCR amplification [34]. To address this potential issue
and to quantify the amount of chimeric amplicons gen-
erated during the second (non-emulsion) stage of our
method, we generated and mixed four defined clonal
HC-LC amplicons (from the Top1, Top2, Top3, and
Top4 antibodies), performed the secondary PCR step
and sequenced the resulting amplicons on the MiSeq
platform with 2 × 250 bases (Additional file 1: Figure
S6a–c). In parallel, we also sequenced the initial clonal
amplicons individually as control for amplicon purity
before secondary PCR. The reads generated from the
initial amplicons before PCR showed > 99.6% correct
HC-LC pairs (Additional file 1: Figure S6d), with < 0.4%
chimeras that were probably generated during bridge
a b
Fig. 3 Binding studies of selected IgG antibodies induced in the post-Td booster immunization sample. a Fourteen highly induced HC-LC pairs
including one known TT antigen-specific HC-CDR3 sequence were cloned into IgG HC and LC expression vectors, co-transfected, and expressed
in HEK 293T cells for production of IgG mAbs. b Indirect ELISA using TT antigen and transfected HEK 293T cell supernatants reveals four novel anti-TT
antibodies (named Top1, Top2, Top3, and Top4). A commercial TT-specific mAb used as positive control in the assays (anti-TT mAb) resulted in a strong
signal while the negative controls (Mock – Mock transfection; HEK 293T – Cell culture supernatant from untransfected cells) resulted in low
background signals
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amplification for cluster generation on the MiSeq flow
cell. Analysis of the reads from the mixed amplicons
after secondary PCR showed that the PCR step indeed
generated chimeric amplicons, with the extent of chimer
formation depending on the sequence identity among
amplicons (Additional file 1: Figure S6e). The three
amplicons from the Top1, Top3, and Top4 antibodies,
sharing HC V genes from the same IGHV3 superfamily,
showed 10–14% chimera formation among each other,
while the Top2 amplicon with IGHV1 superfamily V
gene formed < 0.3% chimeras with the other three
amplicons. The average amount of chimeric amplicon
formation was 18.3% for the four amplicons tested here.
Discussion
We developed a simple, cost-effective, and innovative
approach for high-throughput sequencing of native anti-
body HC-LC pairs from B cell populations. In contrast
to current paired Ig repertoire sequencing technologies
[9–12, 15, 35], this method does not require the physical
separation of single B cells using a flow cytometer, the
construction of a flow focusing apparatus, or complex
microfluidic devices. Our simple method relies on prep-
aration of rER microsomes from B cells using a table-
top centrifuge, avoiding ultracentrifugation steps [28].
The use of rER microsomes to link native HC-LC pairs
in emulsion droplets overcomes previously reported dif-
ficulties involving cell entrapment in emulsion droplets,
cell lysis, and RNA degradation during PCR [35, 36].
Due to the removal of the bulk genomic DNA and non-
secretory RNA during microsome preparation, PCR
artefacts due to off-target amplification by mispriming
are greatly reduced. The simplicity of this method
makes it widely applicable, also for laboratories with-
out specialized equipment.
We report that our method can efficiently capture thou-
sands of antibody HC-LC clonal pairs (Additional file 2:
Data files S1–S4) by processing over one million B cells
per experiment. Our observation that the top ten HC-LC
sequence pairs accounted for 49–76% of the total aligned
reads indicated a skewed clonotype distribution in the
sequenced repertoires. An explanation for this is that our
method predominantly detects antibody mRNAs that are
present in higher abundance in the analyzed B cell popula-
tion. This is because this method does not use single
intact B cells, but rather ER microsomes derived from B
cells, for antibody chain assembly. Cells with larger
secretory ER volumes, which are secreting high amounts
of antibodies, contribute a larger fraction of antibody
sequences to the resulting dataset. Therefore, we expect
that our data does not reflect actual B cell frequencies, but
instead reflects the amounts of secreted antibody mole-
cules. Thus, the thousands of heavy-light chain pairs we
detected from over one million B cells represent the
subset of cells with the highest antibody production (e.g.
plasma cells), which is actually a very interesting cell sub-
set when looking for antigen-specific antibodies. Also, we
noticed preferential amplification of certain V-gene seg-
ments [8, 37], reflecting amplification biases in favor of
the primers used for the VK1 and VK3 LC gene families
(Fig. 2b–e), and thus the reported HC-LC pairs inad-
equately represent the actual clonal frequencies. However, a
more accurate estimate of the human B cell repertoire
using our method is possible through integrating relatively
simple optimizations such as minimization of PCR primer
biases by adjusting primer concentrations, limiting the
amplification cycles as well as by the use of unique molecu-
lar identifiers (UMI) to reduce sequence-dependent amplifi-
cation biases in the nested PCR amplification [37, 38].
We observed that the IgM repertoires obtained from
CD19+ B cells demonstrated relatively low clonal
diversity in the pre-immunization sample in comparison
to the post-immunization sample. In contrast, the IgG
clonal diversity in the post-immunization sample is
lower than in the pre-immunization sample, indicating
that post-immunization, the IgG repertoire was domi-
nated by antigen-experienced clonal pairs.
We showed that our paired antibody sequencing
method was adequately sensitive in detecting antigen-
specific B cell clones occurring at lower frequencies.
This was demonstrated by the identification of three out
of four novel TT-specific antibody sequences that were also
found at low frequencies in the IgG pre-immunization sam-
ple. Our method can therefore track the expansion of B
cells from pre- to post-immunization [2, 24] for the discov-
ery of antigen-specific mAbs [1–3, 10]. However, it must be
noted that our method, as reported here, is dependent on
highly expanded sequences post-immunization in order to
identify novel antigen-specific sequences, thereby limiting
the application of our method to identify antigen-specific
sequences from pre-immunization samples. An improved
strategy to determine antigen-specific antibody sequences
from B cell repertoires before immunization would be to
pre-sort or enrich B cells according to antigen specificity,
so that the resulting paired antibody sequences are highly
enriched for antigen-specific sequences [39].
Using a set of defined amplicons, we detected an
average amount of 18.3% chimeric amplicon formation
during the second (non-emulsion) stage of our method,
which is below an extent that would prevent the applic-
ability of this method for rapid discovery of mAbs. We
expect that also our repertoire data from human B cells
before and after immunization contains similar numbers
of chimeric amplicons, which would account for the ob-
servation that the pairing accuracy is less than what
would be expected from the initial experiments using
mouse hybridomas. Interestingly, the mouse hybridoma
sequences used for establishment of the method showed
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only ~ 0.2% chimeric amplicons, probably due to their
very divergent V gene sequences from distant V gene
superfamilies. A method-specific mitigation strategy for
computational removal of chimera pairs could be based
on the inclusion of short unique molecular identifier
(UMI) sequences next to the overlap sequence for heavy
chain assembly in the central part of the amplicons.
These UMIs can be sequenced using an additional index
read, which is possible on the MiSeq platform. The UMI
sequences could then be used to computationally re-
move lower-frequency (chimeric) LC sequences for each
specific combination of HC and UMI sequence, keeping
only the most frequent truly paired light chains.
The whole process – from B cell isolation to sequen-
cing paired Ig repertoires and analyzing HC-LC se-
quences – takes only four days. Antibody validation can
be carried out within two weeks after sequencing data
acquisition [10, 40]. Our approach can be combined
with bioinformatic tools [41] or conventional screening
technologies [42–45] to facilitate the rapid identification
of antigen-specific mAbs thereby circumventing labori-
ous large-scale screening of combinatorial B cell libraries
[2, 45].
Conclusions
The presented method provides a simple, cost-effective,
and scalable platform to characterize native antibody HC-
LC pairs at single-cell level for rapid identification and
generation of antigen-specific monoclonal antibodies with
minimal costs using only common laboratory equipment.
Our simple method using rER-associated mRNAs to
retain paired antibody HC-LC information from single
cells can be widely applicable in labs that do not have
commercially available specialized equipment. We antici-
pate that this technology could possibly accelerate transla-
tional research towards antibody discovery for diagnostics,
therapeutics, cancer immunotherapies, and investigating
immune responses to vaccination, cancer neoantigens,
and various aspects of immune biology research.
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